ESR2 and breast cancer: In addition, ID4, another factor highly induced by the ERβ variants has been shown to control mammary stem cells and mark breast cancers with a stem cell like phenotype [25] and when expressed in prostate cancer is associated with increased risk for distant metastases [43].